BioSpace News Archive

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that the Company’s presentation time at Barclays Global Healthcare Conference has been changed as follows.

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world, announced that the Company has entered into an exclusive distribution agreement

Aurora Cannabis Inc. announced that it has appointed Nelson Peltz as a Strategic Advisor.

ArQule, Inc. announced that Peter Lawrence, President and Chief Operating Officer, and Brian Schwartz, MD, Chief Medical Officer and Head of Research and Development, of ArQule will present at Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019 at 10:20 a.m. ET at the Westin New York Grand Central in New York City.

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced its financial results for the fourth quarter and full year ending December 31, 2018.

Spectrum Pharmaceuticals announced that an overview of the company’s business strategy and development-stage programs will be given at the Oppenheimer 29th Annual Healthcare Conference being held in New York.

Shawn Iadonato, CEO of Kineta, Inc., was Presented with the “Entrepreneur of the Year” Award and Long-time Member Robin Foote Received “Most Active Investor” Award

Results From Francais WATER and WATER II Studies Will Be Presented at the European Association of Urology Annual Congress

Company to Accelerate International Expansion and Further Investments in AI, Machine Learning, and Digital Clinical Trials

-Biohaven remains on-track for new drug application (NDA) submission for rimegepant Zydis ODT and tablet formulation in 2Q2019